Keith is a seasoned market analyst with decades of experience, known and admired for his perspectives and insights, as well as a highly accurate track record of both predictions and trades.
At just 15, he started advising institutions and qualified individuals, and specializing in non-directional trading.
Today Keith is a regular guest on Fox Business, CNBC Asia, and BNN. He's also a bestselling author. His book, "Fiscal Hangover: How to Profit from the New Global Economy" (John Wiley & Sons), continues to garner rave reviews.
Keith has been leading as Chief Investment Strategist since 2008. He's also the editor of
Keith holds a BS in management and finance from Skidmore College and an MS in international finance (with a focus on Japanese business science) from Chaminade University. He splits his time between the United States and Japan, and regularly travels the world in search of investment opportunities others don't yet see or understand.
Kent is an internationally recognized expert in oil and natural gas policy, risk management, emerging market economic development, and market risk assessment.
He serves as an advisor to the highest levels of the U.S., Russian, Kazakh, Bahamian, Iraqi, and Kurdish governments, to the governors of several U.S. states, and to the premiers of two Canadian provinces. He's served as a consultant to private companies, financial institutions and law firms in 25 countries, and has appeared more than 1,400 times as a featured radio-and-television commentator. He appears regularly on ABC, BBC, Bloomberg TV, CBS, CNN, NBC, Russian RTV, and the Fox Business Network.
Kent is also a professor in the Graduate Center for Social and Public Policy at Duquesne University, where he directs the Energy Policy Research Group. A prolific writer and lecturer, his six books, more than 750 professional and market publications, and over 250 private/public sector presentations and workshops have appeared in 44 countries.
He makes specific investment recommendations in his newsletter, the Energy Advantage. For more active investors, he issues shorter-term trades in his Energy Inner Circle. And Kent’s exclusive Micro Energy Trader is a “swing for the fences” service that targets micro-cap energy stocks. Oil & Energy Investor is Kent's e-letter, where he delivers the latest energy news from his travels around the world in his role as a consultant for major companies and governments.
Shah is considered one of the world's foremost experts on the credit crisis.
He not only called for the implosion of the U.S. financial markets, he also predicted the historic rebound that began in March 2009. Shah's open letters to the White House, Congress, and U.S. Treasury secretaries outlined detailed policy options that have been lauded by academics and legislators alike.
His experience and knowledge uniquely distinguish Shah as a "trader's trader." Shah ran his first hedge fund in 1982 from his seat on the floor of the Chicago Board of Options Exchange. When the OEX (options on the Standard & Poor's 100) began trading on March 11, 1983, Shah was working in the pit as a market maker. And along with other traders, he popularized what later became known as the VIX (volatility index). He left Chicago to run the futures and options division of the British banking giant Lloyd's TSB.
Shah went on to originate and run a packaged fixed-income trading desk for Roosevelt & Cross Inc., an old-line New York boutique bond firm, and established that company's listed and OTC trading desks. Shah started another hedge fund in 1999, which he ran until 2003, when he retired to develop land holdings with partners.
Today Shah is the editor of Capital Wave Forecast and Short-Side Fortunes. He also writes our most talked-about publication, an e-letter called Wall Street Insights & Indictments, where he reveals how Wall Street's high-stakes game is really played, and how to win it.
Shah studied economics and psychology at the University of California, Los Angeles.
A former portfolio adviser and a 20-year veteran of the resource market - with special expertise in energy, metals, and mining stocks - Peter uses the close contacts and connections he amassed over the years to exploit the moneymaking potential of every kind of commodity.
As editor of Real Asset Returns, he travels around the world to dig up the latest and greatest profit opportunity, whether it's in gold, silver, oil, coal, potash, chromium, or even water. Peter has also contributed some of the most widely read and highly regarded investing articles on Money Morning.
Peter holds an MBA from McGill University.
Michael A. Robinson is a 34-year Silicon Valley veteran and one of the top technology financial analysts working today.
His work as a consultant, senior advisor and board member for Silicon Valley venture capital firms has placed him at the center of several major tech innovations including robotics used to revolutionize the auto industry... the $160 billion a year "Cloud Computing" industry... and the latest cyber military technologies.
He's also a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. It's no wonder that Silicon Valley defense publications vie for Michael's analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
His status as a leading tech analyst has garnered him rave reviews, too.
As editor of the financial newsletter American Wealth Underground, he amassed an amazing track record. The first analyst to uncover the rare earth mineral crisis, he amassed cumulative gains of 990% for his readers in just 16 months. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies - ones that have the power to sweep across the globe and change the very fabric of our lives - and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.com
Michael has an honors economics degree from the University of Missouri at Columbia. He's also a registered NRA Triple Distinguished Expert in shotgun, pistol, and rifle and one heck of a blues guitarist.
Sid is the investment community's best-kept secret. Since 2009, he has served behind the scenes at Money Map Press as Director of Research, analyzing hundreds of securities and profit opportunities for subscribers. He's an expert in the identification of specific market catalysts with above average potential in a wide variety of industries, but especially the small-cap sector. In his years of research and training, Sid has developed an extreme attention to detail and a passion for identifying unique opportunities the market doesn't yet recognize or even understand. He brings those recommendations to members of his Small-Cap Rocket Alert.
Sid is also an accomplished drummer and music producer.
Ernie Tremblay has over 20 years' experience studying and writing about the latest developments in health, medicine, and related technologies. He understands the FDA approval process, the "hard science" behind these drugs, and the market demand for them, better than almost anyone else on earth. He has mastered the complex dynamics that determine whether a new drug will be a breakthrough winner - or just another casualty of the FDA approval process.
He has edited books on science, microbiology, and groundbreaking medical therapies for top publishers like Harper Collins, Penguin Putnam, and Prentice Hall. He's also co-authored and contributed to books and articles on diseases from Alzheimer's to rheumatology. Over the decades, Ernie has gained "insider" access to some of the world's top medical professionals, including Nobel-caliber doctors like Yale's Karel Liem, Columbia's George Gaylord Simpson, and Harvard's William S. Beck.
As a guest editor for Money Map Press since 2012, Ernie has already given readers opportunities to land substantial gains - including one bioscience stock that brought readers triple-digit gains four times in eight months. Now he's putting his developed knowledge of the inner workings of the FDA drug approval process to work for members of his BioScience Millionaire service, showing them precisely when a new drug or medical technology is about to give a calendar "pop" to a company's share price.